SEC Form 4 · accession 0000950138-18-000045
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald K. Lloyd
Officer — Exec. VP & Pres, Hospital
Period of report
Jan 4, 2017
Accepted (ET)
Jan 5, 2018 · 7:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jan 4, 2017 | F | 293 | $53.19 | D | 18,021 | D | |
| Ordinary Shares | Jan 3, 2018 | F | 1,068 | $23.51 | D | 16,953 | D | |
| Ordinary Shares | Jan 4, 2018 | F | 299 | $23.40 | D | 16,654 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 347 shares acquired between June 30, 2017 and December 31, 2017 under the Mallinckrodt employee stock purchase plan.